SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy

Name: SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy
License: Public Domain

Zhigang Li

ClinicalTrials.gov · Datasets · License: Public Domain

escc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 424168
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.